Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma
Clinical trial NCT04303403 · UNKNOWN
Trial details
- NCT number
- NCT04303403
- Sponsor
- National Cancer Centre, Singapore
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-31
- Primary completion
- 2023-06-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.